Resultats globals: 1 registres trobats en 0.02 segons.
Articles, 1 registres trobats
Articles 1 registres trobats  
1.
7 p, 1.3 MB Absolute and relative psoriasis area and severity indices (PASI) for comparison of the efficacy of ixekizumab to etanercept and placebo in patients with moderate-to-severe plaque psoriasis : An integrated analysis of UNCOVER-2 and UNCOVER-3 outcomes / Puig Sanz, Lluís (Institut d'Investigació Biomèdica Sant Pau) ; Dossenbach, Martin (Eli Lilly and Company) ; Berggren, Lovisa (Lilly Deutschland GmbH) ; Ljungberg, Anders (Eli Lilly and Company) ; Zachariae, Claus (University of Copenhagen) ; Universitat Autònoma de Barcelona
Treatment goals defined by the absolute Psoriasis Area and Severity Index (PASI) scores offer certain advantages in the clinical setting. In order to investigate potential treatment targets, this study evaluated absolute PASI outcomes relative to other measures of response using data from two randomized clinical trials of patients with moderate-to-severe psoriasis treated with ixekizumab, etanercept, or placebo (n=2,567). [...]
2019 - 10.2340/00015555-3245
Acta dermato-venereologica, Vol. 99 Núm. 11 (october 2019) , p. 971-977  

Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.